CRT 2026
Coronary
Rhian E. Davies, DO MS
Interventional Cardiology
WellSpan York Hospital
Annville, Pennsylvania, United States
Disclosure(s): Terumo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Rajesh Sachdeva, MD, FACC, FSCAI
Associate Professor of Medicine
Emory University School of Medicine, Georgia, United States
Disclosure(s): No financial relationships to disclose
Craig Thompson, MD, MMSc
Director, Interventional Cardiology Hartford Healthcare Heart and Vascular Institute
Hartford Healthcare
Hartford, Connecticut, United States
Disclosure(s): kardion: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Robert-Jan M. van Geuns, MD, PhD
Cardiologist
RadboudUMC
Nijmegen, Gelderland, Netherlands
Disclosure(s): Abbott Vascular,: Grant/Research Support (Ongoing); InfraRedx: Grant/Research Support (Terminated, February 24, 2026), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, February 24, 2026)
Khaldoon Alaswad, MD, FACC, FSCAI
Director, Catheterization Laboratory
Henry Ford Hospital and Health System
Detroit, Michigan, United States
Disclosure(s): No financial relationships to disclose
Tim A. Fischell, MD, FACC, MSCAI
Director of Cardiovascular Research
Borgesd Heart Institute
Kalamazoo, Michigan, United States
Disclosure(s): Balosmark, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); VivaCath, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)
John Daniel Puskas, MD PhD(hc)
Professor of Cardiothoracic Surgery
Emory University
Atlanta, Georgia, United States
Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Scanlan Inc: Royalties on sale of coronary surgery instruments designed by Puskas (Ongoing)
Tuomas T. Rissanen, MD, PhD
Head of Heart Center
North Karelia Central Hospital
Joensuu, Pohjois-Karjala, Finland
Disclosure(s): Abbott Vascular: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); B Braun Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis, Endovascular Division: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Alpesh Shah, MD
Director of Coronary Interventions, Associate Professor
Houston Methodist Hospital
Houston, Texas, United States
Disclosure(s): No financial relationships to disclose
Adhir Shroff, MD, MPH
Clinical Chief of Cardiology
University of Illinois at Chicago/Jesse Brown Medical Center
Chicago, Illinois, United States
Disclosure(s): No financial relationships to disclose
Shana Tehrani, MD, MRCP
Interventional Cardiology Consultant
Frimley Park Hospital, Surrey, UK, United Kingdom
Disclosure(s): No financial relationships to disclose